Literature DB >> 33684713

Quinoline-sulfamoyl carbamates/sulfamide derivatives: Synthesis, cytotoxicity, carbonic anhydrase activity, and molecular modelling studies.

Elmas Begum Cakmak1, Belma Zengin Kurt2, Dilek Ozturk Civelek3, Andrea Angeli4, Atilla Akdemir5, Fatih Sonmez6, Claudiu T Supuran7, Mustafa Kucukislamoglu8.   

Abstract

Carbonic anhydrase (CA) IX, and XII isoforms are known to be highly expressed in various human tissues and malignancies. CA IX is a prominent target for some cancers because it is overexpressed in hypoxic tumors and this overexpression leads to poor prognosis. Novel twenty-seven compounds in two series (sulfamoylcarbamate-based quinoline (2a-2o) and sulfamide-based quinoline (3a-3l)) were synthesized and characterized by means of IR, NMR, and mass spectra. Their inhibitory activities were evaluated against CA I, CA II, CA IX, and CA XII isoforms. 2-Phenylpropyl (N-(quinolin-8-yl)sulfamoyl)carbamate (2m) exhibited the highest hCA IX inhibition with the Ki of 0.5 µM. In addition, cytotoxic effects of the synthesized compounds on human colorectal adenocarcinoma (HT-29; HTB-38), human breast adenocarcinoma (MCF7; HTB-22), human prostate adenocarcinoma (PC3; CRL-1435) and human healthy skin fibroblast (CCD-986Sk; CRL-1947) cell lines were examined. The cytotoxicity results showed that 2j, 3a, 3e, 3f are most active compounds in all cell lines (HT-29, MCF7, PC3, and CCD-986Sk).
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CA inhibition; Cytotoxicity; Molecular docking; Molecular dynamics simulations; Quinoline; Sulfamide; Sulfamoyl carbamate

Year:  2021        PMID: 33684713     DOI: 10.1016/j.bioorg.2021.104778

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  1 in total

1.  Synthesis, Carbonic Anhydrase II/IX/XII Inhibition, DFT, and Molecular Docking Studies of Hydrazide-Sulfonamide Hybrids of 4-Methylsalicyl- and Acyl-Substituted Hydrazide.

Authors:  Adil Khushal; Amara Mumtaz; Wamda Ahmed Shadoul; Syeda Huda Mehdi Zaidi; Hummera Rafique; Abida Munir; Aneela Maalik; Syed Jawad Ali Shah; Ayesha Baig; Wajiha Khawaja; Mariya Al-Rashida; Muhammad Ali Hashmi; Jamshed Iqbal
Journal:  Biomed Res Int       Date:  2022-02-24       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.